SphK1 inhibitor potentiates the anti-cancer effect of EGCG on leukaemia cells

Shuntaro Tsukamoto, Motofumi Kumazoe, Yuhui Huang, Connie Lesnick, Neil Elliot Kay, Tait D. Shanafelt, Hirofumi Tachibana

Research output: Contribution to journalArticle

5 Scopus citations
Original languageEnglish (US)
JournalBritish Journal of Haematology
DOIs
StateAccepted/In press - 2016

Keywords

  • Apoptosis
  • Chronic lymphocytic leukaemia
  • Epigallocatechin-O-3-gallate
  • Safingol
  • Sphingosine kinase 1

ASJC Scopus subject areas

  • Hematology

Cite this

Tsukamoto, S., Kumazoe, M., Huang, Y., Lesnick, C., Kay, N. E., Shanafelt, T. D., & Tachibana, H. (Accepted/In press). SphK1 inhibitor potentiates the anti-cancer effect of EGCG on leukaemia cells. British Journal of Haematology. https://doi.org/10.1111/bjh.14119